CG-3-246
CG-3-246 is a dual inhibitor of FLT3/BCL-2, with the Kds of 63 and 4.25 nM, respectibely. CG-3-246 plays an important role in acute myeloid leukemias research.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- 화학식: C64H73ClN14O10S
- 분자량:1265.87
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Chemical Information
-
분자량 1265.87
-
화학식 C64H73ClN14O10S
-
SMILES
O=C(C1=NC(CC)=C(NC2CCOCC2)N=C1NC3=CC=C(N4CCN(C(CNC5=CC=C(S(=O)(NC(C6=CC=C(N7CCN(CC8=C(C9=CC=C(Cl)C=C9)CC(C)(C)CC8)CC7)C=C6OC%10=CN=C(NC=C%11)C%11=C%10)=O)=O)C=C5[N+]([O-])=O)=O)CC4)C(OC)=C3)N
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
[1]. Christopher C Goodis, et al. The polypharmacy combination of the BCL-2 inhibitor venetoclax (VEN) and the FLT3 inhibitor gilteritinib (GIL) is more active in acute myeloid leukemia cells than novel polypharmacologic BCL-2/FLT3 VEN–GIL hybrid single-molecule inhibitors. Eur J Med Chem. 2024 Dec 22:285:117190. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)